Cannara Biotech names Nicholas Fozard as CFO

Cannara Biotech Inc. (TSX: LOVE, OTCQX: LOVFF, FRA: 8CB0) has appointed Nicholas Fozard, CPA, as Chief Financial Officer, according to a press release from the Montreal-based cannabis producer. The appointment will take effect upon Fozard's receipt of a Health Canada security clearance.

Fozard brings more than a decade of cannabis finance experience. He previously served as Vice President, Finance at Organigram Global and Senior Vice President, Finance at iAnthus. He began his career at PwC. He holds an MBA from the Kellogg–Schulich Executive MBA Program, a Global Professional Master of Laws from the University of Toronto, and an Honours Bachelor of Commerce from McMaster University.

The appointment completes a leadership transition Cannara announced on May 6, 2026. Niko Sosiak, who served as CFO from 2020, was appointed Chief Operating Officer on April 23, 2026, and continued as interim CFO during the search for a replacement. Sosiak will now transition fully into the COO role.

"His extensive cannabis-sector finance experience, combined with his background in public-company reporting, manufacturing finance, capital markets and transactions, makes him a strong addition to our leadership team," said Zohar Krivorot, Founder and CEO of Cannara.

You May Also Be Interested In

• Cannara Appoints Nicholas Fozard as Chief Financial Officer
• Invivyd names chairman Marc Elia as CEO ahead of VYD2311 data
• Apollo Silver names Steven Thomas as new CFO effective Sept. 1